FindTrial
Sign In

Madhuyashtyadi Taila Matra Basti in Vatarakta (Hyperuricemia)

Evaluation Of Madhuyashtyadi Taila Matra Basti In Vatarakta (Hyperuricemia)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033631
Enrollment
60
Registered
2021-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

Intervention1: Madhuyashtyadi Taila Matra Basti: Patients will be administered Madhuyashtyadi Taila Matra Basti in a dose of 60 ml daily for 15 days. Control Intervention1: Allopurinol: Patients will

Sponsors

UAU Gurukul Campus Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Increased serum uric acid level more than 7mg/dL in male, more than 6mg/dL in female. 2 Age group between 20-60 years. 3)Patients will be selected irrespective of sex, religion, occupation, habitat etc. 4)Patients fit for Basti karma. 5)Sign and Symptoms of Vatarakta.

Exclusion criteria

Exclusion criteria: 1)Patients of Vatarakta with any chronic systemic disorder which interferes with the present study. 2)Patients of Vatarakta having any severe arthritic condition. 3)Patients with long standing use of corticosteroids. 4)Patients having serious systemic disorders (like chronic heart diseases, chronic renal disorders). 5)Patients with autoimmune diseases. 6)Patients with serious medical illness and psychiatric disorder. 7)Pregnant female and lactating mothers.

Design outcomes

Primary

MeasureTime frame
Relief in Subjective Parameters like: 1)Kandu (Itching) 2)Daha (Burning sensation) 3)Ruka (Pain) 4)Toda (Pricking pain) 5)Sphurana (Throbbing sensation) 6)Aakunchana (Contraction) 7)Vavaranaya (Discoloration) 8)Shyava rakta tvaka (Brownish black, red coloration of the skin) 9)Tamra tvaka (Coppery coloration of the skin) 10)Shvayathu (Oedema) 11)Stabdhata (Stiffness) 12)Kathinya (Hardness) 13)Paka (Suppuration of the joints)Timepoint: At 1st, 15th and 45th day—

Secondary

MeasureTime frame
Relief in Objective Parameters- 1)Serum uric acid 2)Investigation â?? Blood- Hemoglobin, Total leucocyte count, Differential leucocyte count, Erythrocyte sedimentation rate. 3)Urine: Routine & microscope examination. 4)RA factor 5)CRP Timepoint: 1st, 15th and 45th day—

Countries

India

Contacts

Public ContactDr Gyanendra Datta Shukla

UAU, Gurukul Campus, Haridwar

dr.gdshukla@gmail.com8791265576

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026